NASDAQ:TRIB Trinity Biotech (TRIB) Stock Price, News & Analysis $7.15 +1.38 (+23.92%) Closing price 04:00 PM EasternExtended Trading$6.82 -0.34 (-4.69%) As of 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsNews and TrendsOptions ChainOwnershipSEC Filings About Trinity Biotech Stock (NASDAQ:TRIB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Trinity Biotech alerts:Sign Up Key Stats Today's Range$5.97▼$7.3450-Day Range$5.69▼$13.3852-Week Range$5.01▼$52.50Volume41,578 shsAverage Volume24,215 shsMarket Capitalization$5.81 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Trinity Biotech plc is a biotechnology and medical diagnostics company headquartered in Ireland. The company develops, manufactures and markets diagnostic products used by clinical laboratories, healthcare providers and other testing facilities. Its offerings are designed to support the detection and management of infectious diseases, autoimmune conditions and other medical disorders. Trinity Biotech’s portfolio has historically included point-of-care and laboratory-based tests for conditions such as HIV, hepatitis, syphilis and autoimmune diseases. The company has also provided clinical laboratory services and diagnostic technologies, serving healthcare markets in North America, Europe and other international regions through direct operations, distributors and strategic relationships. Founded in 1992, Trinity Biotech has expanded through internal development and acquisitions of diagnostic businesses and technologies. Its products are used in a range of settings, including hospitals, reference laboratories, physician offices, public-health programs and resource-limited environments where rapid testing can be important.AI Generated. May Contain Errors. Read More Trinity Biotech Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks11th Percentile Overall ScoreTRIB MarketRank™: Trinity Biotech scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingTrinity Biotech has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageTrinity Biotech has only been the subject of 1 research reports in the past 90 days.Read more about Trinity Biotech's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Trinity Biotech is -0.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Trinity Biotech is -0.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Trinity Biotech's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.07% of the float of Trinity Biotech has been sold short.Short Interest Ratio / Days to CoverTrinity Biotech has a short interest ratio ("days to cover") of 0.56, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Trinity Biotech has recently decreased by 18.82%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTrinity Biotech does not currently pay a dividend.Dividend GrowthTrinity Biotech does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Trinity Biotech this week, compared to 1 article on an average week.MarketBeat Follows1 people have added Trinity Biotech to their MarketBeat watchlist in the last 30 days. Company Ownership1.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Trinity Biotech insiders have not sold or bought any company stock.Percentage Held by Insiders8.20% of the stock of Trinity Biotech is held by insiders.Percentage Held by Institutions78.97% of the stock of Trinity Biotech is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Trinity Biotech's insider trading history. Receive TRIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TRIB Stock News HeadlinesCritical Comparison: Trinity Biotech (NASDAQ:TRIB) & Nuwellis (NASDAQ:NUWE)September 28, 2026 | americanbankingnews.comTrinity Biotech Signs Contract With Red Team Investments For AI Data Center Cooling SolutionsSeptember 9, 2026 | rttnews.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.October 6 at 1:00 AM | Porter & Company (Ad)Trinity Biotech’s Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center InfrastructureSeptember 9, 2026 | finance.yahoo.comTrinity Biotech's Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center InfrastructureSeptember 9, 2026 | globenewswire.comTrinity Issues Updates On Diagnostics Launch; Plans To Regain Nasdaq Compliance By Feb '27August 31, 2026 | rttnews.comTrinity Biotech Provides Diagnostics Business, Transformation And Corporate UpdateAugust 28, 2026 | globenewswire.comTrinity Biotech’s Trinovium Subsidiary Agrees to Collaborate with Echelon Data Centres to Develop Advanced Liquid Cooling Solutions for AI InfrastructureAugust 17, 2026 | finance.yahoo.comSee More Headlines TRIB Stock Analysis - Frequently Asked Questions How have TRIB shares performed this year? Trinity Biotech's stock was trading at $23.73 at the beginning of the year. Since then, TRIB shares have decreased by 69.9% and is now trading at $7.15. How were Trinity Biotech's earnings last quarter? Trinity Biotech PLC (NASDAQ:TRIB) announced its earnings results on Tuesday, June, 16th. The company reported ($6.90) earnings per share for the quarter, topping analysts' consensus estimates of ($9.30) by $2.40. The business had revenue of $10.85 million for the quarter, compared to analysts' expectations of $10.68 million. When did Trinity Biotech's stock split? Trinity Biotech's stock reverse split on Friday, July 24th 2026.The 1-30 reverse split was announced on Friday, July 24th 2026. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 24th 2026. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. How do I buy shares of Trinity Biotech? Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Trinity Biotech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Trinity Biotech investors own include Bristol Myers Squibb (BMY), Micron Technology (MU), OPKO Health (OPK), Novavax (NVAX), Corbus Pharmaceuticals (CRBP), Gilead Sciences (GILD) and Pfizer (PFE). Company Calendar Last Earnings6/16/2026Today10/06/2026Next Earnings (Estimated)12/10/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (6m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 TRIB's financial health is in the Red zone, according to TradeSmith. TRIB has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolNASDAQ:TRIB CIK888721 Webwww.trinitybiotech.com Phone(531) 276-9800Fax353-1276-9888Employees287Year Founded1992Profitability EPS (Trailing Twelve Months)($44.26) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$37.38 million Net Margins-70.06% Pretax Margin-69.70% Return on EquityN/A Return on Assets-32.13% Debt Debt-to-Equity RatioN/A Current Ratio0.22 Quick Ratio0.09 Sales & Book Value Annual Sales$43.78 million Price / Sales0.13 Cash FlowN/A Price / Cash FlowN/A Book Value($601.80) per share Price / Book-0.01Miscellaneous Outstanding Shares810,000Free Float746,000Market Cap$5.79 million OptionableOptionable Beta0.73 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:TRIB) was last updated on 10/6/2026 by MarketBeat.com Staff. From Our PartnersNvidia’s record quarter could send this new type of AI soaringNvidia just posted 96.2 billion in revenue for a single quarter, more than Coca-Cola generates in an entire ye...Brownstone Research | SponsoredMILLIONAIRE MASTERCLASS INVITE: AltucherJames Altucher says Elon Musk is preparing an unprecedented project set to surface on December 8th. Altuche...Paradigm Press | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | SponsoredDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...Porter & Company | SponsoredThey're not telling you how bad this could getValuations have reached levels seen only a handful of times in the past century, while debt concerns and tarif...Parkview Capital Group | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Trinity Biotech With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRIB Stock Alerts